ARCAIDIUM LTD

Company number 15207643 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ARCAIDIUM LTD - Analysis Report

Company Number: 15207643

Analysis Date: 2025-07-29 21:01 UTC

Financial Health Assessment: ARCAIDIUM LTD (as at 31 December 2024)


1. Financial Health Score: D

Explanation:
The company shows early-stage financial strain with net current liabilities and negative shareholders' funds. Although a new company (incorporated October 2023), the balance sheet reveals symptoms of financial distress — notably working capital deficiency and negative equity. This results in a below-average rating, reflecting risk but also the potential for recovery with proper management.


2. Key Vital Signs

Metric Value (£) Interpretation
Current Assets 426,106 Adequate liquidity pool, dominated by cash (418,536), which is a positive sign.
Current Liabilities 449,965 High short-term obligations, exceeding current assets, indicating liquidity pressure.
Net Current Assets (Working Capital) -23,859 Negative working capital signals that short-term debts exceed short-term assets — a symptom of liquidity stress.
Fixed Assets 2,693 Minimal investment in long-term assets, typical for a startup or service-oriented firm.
Shareholders' Funds (Equity) -21,170 Negative equity indicates accumulated losses or funding shortfall, a warning sign of financial health.
Cash on Hand 418,536 Healthy cash balance, a vital lifeline supporting ongoing operations despite liabilities.
Called Up Share Capital 4 Very small capital base, typical for a newly incorporated company.

3. Diagnosis

ARCAIDIUM LTD is in its infancy, having operated just over a year. The financial "vitals" reveal:

  • Liquidity Symptoms: Despite a strong cash position (£418k), current liabilities slightly exceed current assets leading to negative working capital (-£23.9k). This suggests the company may face short-term cash flow tightness if liabilities crystallize suddenly. The large accruals and deferred income (£299k) and director loans (£81.7k) underpin these liabilities, showing reliance on internal funding and deferred expenses.

  • Capital Structure: Negative shareholders' funds (-£21k) indicate the company has accumulated losses or invested capital that is currently insufficient to cover liabilities. This "symptom" commonly occurs in startups investing heavily in early growth phases before turning profitable.

  • Going Concern: Directors have assessed the company as a going concern, relying on projected cash flows and funding. However, the margin for error is thin given current liabilities exceed liquid assets by a small margin.

  • Operational Status: The company employs 6 people and operates in a professional scientific/technical sector, likely involving consultancy or R&D activities. Fixed assets are minimal, consistent with a service-heavy business model.

Overall, the financial "patient" shows early signs of stress but not critical illness. The healthy cash flow (cash reserves) is a positive lifeline, but the working capital deficit and negative equity are warning signals requiring close management.


4. Recommendations

To improve financial wellness and transition towards a stable and healthy financial state, ARCAIDIUM LTD should consider:

  • Improve Working Capital Management:

    • Accelerate debtor collections and monitor credit control rigorously.
    • Negotiate longer payment terms with creditors to ease immediate cash outflows.
    • Reduce accrued expenses where possible or convert some liabilities into longer-term funding.
  • Strengthen Capital Base:

    • Consider additional equity injections to rebuild shareholders’ funds and provide a buffer against liabilities.
    • Explore grants or external funding opportunities suitable for scientific and technical startups.
  • Monitor Cash Flow Closely:

    • Maintain daily cash flow forecasts to avoid liquidity crises.
    • Limit discretionary spending and prioritize essential operational expenses.
  • Operational Efficiency:

    • Evaluate employee productivity relative to revenue generation to avoid overstaffing.
    • Invest strategically in assets or intellectual property that can drive future profitability.
  • Governance and Reporting:

    • Although exempt from audit, consider voluntary external reviews to reassure stakeholders and identify financial risks early.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.